are resistant to various antibiotics. Staphylococci are the normal inhabitants of human skin and mucous membranes. Staphylococci play a role in bacteremia, endocarditis, urinary tract infections, surgical site infections, and so on. MRSA are prevalent worldwide and are an important cause of nosocomial infections, resulting in an increased morbidity and mortality in the hospital settings worldwide. In order to treat the penicillin-resistant S. aureus, methicillin was first introduced in human medicine in the 1960s, but within a few years, MRSA emerged. The extent to which S. aureus causes its effect on human ranges from minor skin diseases to life-threatening infections.
Introduction
Methicillin-resistant strains of Staphylococcus aureus (MRSA) are implicated in serious infections and nosocomial outbreaks. The choices of treatment are reduced, as they that has a low affinity for β-lactam antibiotics and whose effects are determined by several structural genes (mecA). [2, 3] Other known mechanism of methicillin resistance is the hyperproduction of penicillinase enzyme. [3, 4] Life-threatening sepsis and osteomyelitis caused by MRSA have also been reported. [5] The S. aureus infections commonly showed response to β-lactam and the related group of antibiotics, but the emergence of MRSA has exerted a serious therapeutic challenge. [6] The MRSA strains are spread through the infected and colonized patients in hospitals, and the main source of transmission is the hospitals staff. [7] The possible predisposing factors that increase the chance of emergence and spread of MRSA are prolonged and repeated hospitalization, indiscriminate use of antibiotics, lack of awareness of proper hygiene, intravenous drug abuse, and the presence of indwelling medical devices. [8] As the MRSA are multidrug resistant, it is difficult to eradicate them. [1] It has been found that resistance to glycopeptides drugs was also observed in several parts of the nation. [9, 10] The proper treatment for these infections requires the knowledge of prevalence of MRSA and their antimicrobial-susceptibility pattern. This study was undertaken to assess the prevalance rate of MRSA in our hospital.
Materials and Methods
This study was carried out in the Department of Microbiology, BJ Medical College, Ahmedabad, Gujarat, India. Various clinical samples sent for culture sensitivity examination from tertiary-care civil hospital, Ahmedabad, were included in the study for over a period of 6 months from June to November 2012. All age group patients were included.
All the samples were processed and inoculated on blood agar, nutrient agar, and MacConkey agar. S. aureus was diagnosed by their growth characteristics on MacConkey agar (pink color colony), on nutrient agar (large, circular, and opaque colony), and on blood agar; (grayish white colony), gram-stain morphology (gram-positive cocci in clusters); positive catalase test; positive coagulase test (slide and tube coagulase test); growth on mannitol salt agar; and pigment characteristics (golden yellow).
Antibiotics Susceptibility Testing
The antibiotic susceptibility pattern of all the S. aureus strains were determined by modified Kirby-Bauer disc diffusion method against the following antibiotics: cotrimoxazole (25 μg), ampicillin-sulbactam (20 μg), tetracycline (30 μg), cephalexin (30 μg), ciprofloxacin (5 μg), cloxacillin (1 μg), gentamycin (10 μg), erythromycin (15 μg), clindamycin (2 μg), and linezolid (2 μg). All the tests were performed on MuellerHinton agar and were interpreted after incubation for 24 h at 37°C. The zone diameters measured around each disc were interpreted on the basis of guidelines published by the Clinical and Laboratory Standards Institute (CLSI).
Detection Method for MRSA
Screening was performed according to the CLSI guidelines using cefoxitin disc (30 μg) diffusion testing method.
From each strain, a suspension equivalent to 0.5 McFarland was prepared. Then, a swab was dipped and streaked on the surface of a Mueller-Hilton agar supplemented after incubation for 24 h at 35°C. If the zone of inhibition was ≤21 mm in diameter, the isolate was considered as MRSA [ Figure 1 ]. Confirmation was done by oxacillin minimum inhibitory concentration (MIC) test, Epsilometer test (E-test) on 2% NaCl Mueller-Hinton agar plates; MIC > 4 was considered as methicillin resistance. For this, quality control used were ATCC 25923 S .aureus as negative control and ATCC 43300 S. aureus as positive control [ Figure 2 ]. 
Result
We received a total of 5,046 samples over the duration of 6 months from June to November 2012. Of these, S. aureus was isolated in 232 samples. Forty-seven (20.25%) of these 232 samples were found to be methicillin resistant.
MRSA isolated were in majority form skin and soft tissue samples (71%), followed by blood cultures (15%), miscellaneous (5.26%), and respiratory specimens (4.09%) [ Figure 3 ].
Methicillin-resistant strains were resistant to multiple antibiotics. Resistance to other antibiotics were more encountered in MRSA strains when compared with methicillin-susceptible Streptococcus aureus (MSSA) strains. MRSA strains were highly susceptible to vancomycin, linezolid, and teicoplanin. All MRSA strains isolated were sensitive to vancomycin in our study [ Figure 4 ].
Discussion
MRSA is a major nosocomial pathogen causing significant morbidity and mortality. MRSA is a persistent and ever growing problem for health-care institutions. Data on prevalence of MRSA are variable. Our study showed the prevalence of MRSA as 20% in our hospital.
In our study, MRSA isolated were in majority from skin and soft tissue samples (71%), followed by blood cultures (15%), miscellaneous (5.26%), and respiratory specimen (4.09%); which can be compared with the study done by Shah et al., [11] in which MRSA isolated were in majority from pus samples (74.13%), followed by blood cultures (18.97%), miscellaneous (5.17%), and sputum (1.72%). In the study carried out by Shah et al. and in this study, MRSA were found to be 30.37% and 20.25% of the total isolates of S. aureus, respectively.
In India, the incidence of MRSA shows a large variation, from 6.9% to 81%. Some studies have reported comparable prevalences: 54.8% in Uttar Pradesh, [8] 52.9% in Assam, [12] 80.89% in Indore, [13] and 19.56% in Nagpur. [14] According to a different study carried out by Tesring et al., [15] the prevalance rate was 38.14%, and in the study of Joshi et al. [16] and Arora et al., [17] the prevalance rates were 41% and 46%, respectively.
When compared with few studies described earlier, the prevalence of MRSA in our hospital was found to be quite less. This could be explained on the basis that regular surveillance of hospital-associated infections including antimicrobial susceptibility pattern of MRSA is performed, and infection control measures are taken to prevent the spread of MRSA. Another reason could be that our study included only those samples that were sent for suspected cases. No random samples were selected from patients to detect the presence of MRSA who were not clinically suspected. Thus, this study only detects the prevalence of MRSA in clinically suspected cases whose samples were received for culture and sensitivity examination and not prevalence of MRSA as whole.
With the help of this study, we found out the prevalence of MRSA in our hospital setup. These data will help us further to formulate a better antibiotic policy and to take appropriate infection control measures.
Conclusion
The health-care institutions face constant and evermore problems, because of MRSA. Data on prevalence of MRSA are variable. Our study showed the prevalence of MRSA as 20% in our hospital. The prevalence varies depending on the infection control policy of hospitals. Minimizing the emergence of this organism and its spread remains a challenge that needs to be addressed. A regular surveillance of hospitalassociated infection, including monitoring antibiotic sensitivity pattern of MRSA, is mandatory to control the spread in the hospital and strict drug policy are mandatory. Vancomycin use should be limited to those cases where they are clearly needed. However, owing to the increasing use of vancomycin, regular monitoring of vancomycin sensitivity by MIC for MRSA and routine testing of other new glycopeptides should be carried out further. Prevention and infection control strategies should be applied in tertiary-care hospitals such as general measures (hand hygiene, cleanliness, proper disinfection, use of contact precautions, and education and training of all health-care workers) and specific measures (patient isolation and cohorting, eradication of MRSA carriage, and surveillance and screening of patients and health-care workers).
